Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Vanguard (VRTX) parent reports 0 shares; subsidiaries to report holdings separately
The Vanguard Group has filed an amended SCHEDULE 13G/A for Vertex Pharmaceuticals Inc (VRTX) reporting 0 shares beneficially owned due to an internal realignment effective prior to the amendment. This change means that certain Vanguard subsidiaries will now report their beneficial ownership separately, relying on SEC Release No. 34-39538. The filing explicitly states that the parent company no longer has beneficial ownership over securities held by these disaggregated subsidiaries, and subsequent filings from affiliates are expected to show their individual holdings.